NRC Health (NRC)
NASDAQ: NRC · Real-Time Price · USD
20.08
-0.70 (-3.37%)
Oct 6, 2026, 4:00 PM EDT - Market closed
NRC Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 444 | 425 | 414 | 971 | 921 | 1,056 | |
Market Cap Growth | 57.73% | 2.70% | -57.35% | 5.49% | -12.84% | -2.20% |
Enterprise Value | 531 | 504 | 465 | 992 | 916 | 1,034 |
Last Close Price | 20.08 | 18.31 | 16.64 | 36.57 | 33.36 | 36.35 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 83.53 | 37.66 | 16.71 | 31.36 | 28.96 | 28.20 |
Forward PE | 21.14 | 34.39 | 34.39 | 34.39 | 34.39 | 34.39 |
PS Ratio | 3.17 | 3.10 | 2.90 | 6.54 | 6.07 | 7.14 |
PB Ratio | 67.88 | 30.40 | 13.24 | 19.84 | 12.78 | 12.38 |
P/TBV Ratio | - | - | - | - | 104.51 | 48.15 |
P/FCF Ratio | 20.52 | 27.01 | 21.59 | 43.48 | 34.83 | 25.87 |
P/OCF Ratio | 15.05 | 16.08 | 11.96 | 25.48 | 25.38 | 22.79 |
PEG Ratio | - | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.79 | 3.67 | 3.25 | 6.67 | 6.05 | 6.99 |
EV/EBITDA Ratio | 19.92 | 13.61 | 11.21 | 21.57 | 17.68 | 18.20 |
EV/EBIT Ratio | 29.44 | 17.14 | 13.12 | 24.74 | 19.68 | 20.37 |
EV/FCF Ratio | 24.55 | 31.99 | 24.25 | 44.40 | 34.67 | 25.32 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 13.81 | 5.74 | 2.06 | 0.80 | 0.33 | 0.34 |
Debt / EBITDA Ratio | 3.32 | 2.14 | 1.53 | 0.84 | 0.45 | 0.50 |
Debt / FCF Ratio | 4.18 | 5.10 | 3.36 | 1.74 | 0.89 | 0.70 |
Net Debt / Equity Ratio | 13.30 | 5.44 | 1.92 | 0.66 | -0.02 | -0.30 |
Net Debt / EBITDA Ratio | 3.27 | 2.06 | 1.45 | 0.70 | -0.03 | -0.45 |
Net Debt / FCF Ratio | 4.03 | 4.83 | 3.14 | 1.45 | -0.06 | -0.63 |
Asset Turnover | 1.01 | 1.03 | 1.12 | 1.18 | 1.05 | 1.02 |
Quick Ratio | 0.49 | 0.43 | 0.44 | 0.53 | 1.21 | 1.71 |
Current Ratio | 0.65 | 0.55 | 0.55 | 0.67 | 1.31 | 1.83 |
Return on Equity (ROE) | 42.03% | 51.24% | 61.77% | 51.20% | 40.41% | 50.07% |
Return on Assets (ROA) | 8.13% | 13.73% | 17.38% | 19.81% | 20.21% | 21.80% |
Return on Invested Capital (ROIC) | 12.34% | 21.04% | 31.12% | 40.97% | 53.18% | 63.83% |
Return on Capital Employed (ROCE) | 17.80% | 29.90% | 36.70% | 46.50% | 48.00% | 43.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.23% | 2.73% | 5.99% | 3.19% | 3.45% | 3.55% |
FCF Yield | 4.87% | 3.70% | 4.63% | 2.30% | 2.87% | 3.87% |
Dividend Yield | 3.19% | 2.84% | 2.88% | 1.31% | 2.52% | 1.32% |
Payout Ratio | 266.23% | 94.64% | 46.21% | 117.42% | 65.92% | 24.45% |
Buyback Yield / Dilution | 5.38% | 5.67% | 3.77% | 1.51% | 2.29% | 0.22% |
Total Shareholder Return | 8.57% | 8.51% | 6.65% | 2.83% | 4.81% | 1.54% |